ENZOLYTICS

enzolytics-logo

Enzolytics is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Enzolytics is committed to creating drugs for the better health of mankind.

#People #Website #More

ENZOLYTICS

Industry:
Health Care

Address:
Monrovia, Montserrado, Liberia

Country:
Liberia

Website Url:
http://www.enzolytics.com

Status:
Active

Contact:
(626)-538-4779


Current Employees Featured

not_available_image

Charles S. Cotropia
Charles S. Cotropia CEO @ Enzolytics
CEO
2009-12-01

Official Site Inspections

http://www.enzolytics.com

  • Host name: 209.17.116.165
  • IP address: 209.17.116.165
  • Location: Jacksonville United States
  • Latitude: 30.1426
  • Longitude: -81.5727
  • Metro Code: 561
  • Timezone: America/New_York
  • Postal: 32258

Loading ...

More informations about "Enzolytics"

Enzolytics - Crunchbase Company Profile & Funding

Organization. Enzolytics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Enzolytics is a drug development company. Monrovia, Montserrado, โ€ฆSee details»

Company News - Enzolytics

See details»

Enzolytics, Inc. (ENZC) Company Profile & Facts - Yahoo Finance

See the company profile for Enzolytics, Inc. (ENZC) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives โ€ฆSee details»

Enzolytics Inc - LinkedIn

Enzolytics, Inc. is a Texas based biotech company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the treatment of debilitating infectious โ€ฆSee details»

ENZC - Enzolytics Inc. | Company Profile | OTC Markets

Mar 26, 2025 Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the โ€ฆSee details»

Enzolytics (ENZC) Company Profile & Description - Stock Analysis

Enzolytics Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics โ€ฆSee details»

Enzolytics Inc (ENZC) Profile - The Globe and Mail

See the company profile for Enzolytics Inc (ENZC) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»

Company Enzolytics, Inc. - MarketScreener.com

Mar 18, 2024 Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat โ€ฆSee details»

Enzolytics - Overview, News & Similar companies | ZoomInfo.com

Mar 6, 2024 Enzolytics, Inc. is a drug development company committed to the commercialization of its proprietary proteins and monoclonal antibodies for the tre atment of debilitating infectious โ€ฆSee details»

ENZC | Enzolytics Inc. Company Profile & Executives - WSJ

Company profile for Enzolytics Inc. including key executives, insider trading, ownership, revenue and average growth rates. View detailed ENZC description & address.See details»

Enzolytics - VentureRadar

Enzolytics, Inc. is a Texas-based biotech company committed to the development and commercialization of its proprietary proteins and monoclonal antibodies for the treatment of โ€ฆSee details»

Enzolytics 2025 Company Profile: Stock Performance & Earnings

Enzolytics General Information Description. Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: โ€ฆSee details»

Our Science - Enzolytics

Enzolytics, Inc. is committed to the development and commercialization of its proprietary protein therapeutics for the treatment of debilitating infectious diseases. The Companyโ€™s technology is โ€ฆSee details»

Enzolytics, Inc. CONSOLIDATED BALANCE SHEETS As of December โ€ฆ

ENZOLYTICS, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Note 1. Organization and Business Enzolytics, Inc. (โ€œEnzolyticsโ€ or the โ€œCompanyโ€) is a Delaware โ€ฆSee details»

Company Enzolytics Inc. Other OTC - MarketScreener.com

Jun 15, 2017 Enzolytics, Inc. is a drug development company. The Company is focused on commercializing its licensed proprietary proteins and monoclonal antibodies to treat โ€ฆSee details»

Enzolytics, Inc. Reports Progress and Future Plans - Yahoo Finance

Apr 25, 2022 Enzolytics continues to make significant progress in its multiple therapeutic platforms and outlines here the technical aspects of the implementation of those programs and โ€ฆSee details»

ENZC | News | OTC Markets

Enzolytics, Inc. is transitioning from solely a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating โ€ฆSee details»

Enzolytics (ENZC): Uncovering the Hidden Risks Investors Should โ€ฆ

Nov 26, 2024 Enzolytics faces severe challenges, including limited revenue, legal scrutiny, excessive share dilution, and market competition. The companyโ€™s inability to deliver products โ€ฆSee details»

Enzolytics, Inc. Reports Progress and Future Plans | Nasdaq

Apr 25, 2022 Enzolytics continues to make significant progress in its multiple therapeutic platforms and outlines here the technical aspects of the implementation of those programs and โ€ฆSee details»

5 Reasons Why Enzolytics is a Compelling Choice! - Avise Analytics

Jun 11, 2021 Enzolytics Inc. (OTCPK: ENZC) is leveraging over 40 years of drug development experience to develop proprietary antiviral peptides and monoclonal antibodies for the โ€ฆSee details»